TriLink BioTechnologies Announces Agreement with American Cleanroom Systems to build cGMP Facility
News Oct 24, 2013
The pharmaceutical cGMP production facility will contain nine labs and be equipped to manufacture and process mRNA, long RNA, aptamers, oligonucleotides, small molecules and nucleoside triphosphates. The project is scheduled to be complete in the first quarter of next year.
"Building a pharmaceutical cGMP production facility is the next logical step in expanding our quality system. Soon we will be able to support our customers at every stage from research to clinical trials and commercialization," said TriLink CEO, Richard Hogrefe, Ph.D. "ACS offered the quality and experience we were seeking and we're confident they are the right contractor to help us meet these goals."
The American Society of Human Genetics (ASHG), along with several co-signing organizations, issued a position statement today outlining whether, and to what extent, there is a responsibility to recontact genetic and genomic research participants when new findings emerge that suggest their genetic information should be interpreted differently, which would allow participants to benefit from current genomics advances.READ MORE